Bluestar Adisseo Company (SSE stock code 600299), world leader in nutritional solutions and additives for animal feed, today announces its financial results for the first quarter of 2016.

Jean-Marc Dublanc, CEO of Bluestar Adisseo Company, stated: “The results of this 2016 first quarter are in line with our expectations even though they reflect contrasted market situations. Pursuing our strategy of profitable value-creating growth, Adisseo’s business activity is dynamic, in particular for high added-value products. Our financial results validate our growth strategy based on leadership in methionine and innovation in specialty products. Considering the first achievements beginning of this year, we reiterated our target for net profit attributable to shareholders target for 2016.”

* 3 months of Adisseo business

** 3 months of BNCM business

Q1 2016 FINANCIAL AND OPERATIONAL OVERVIEW

2016 Q1 financial results include solely Adisseo business and 2015 Q1 financial results before restatement include 3 months of BNCM business.

2016 Q1 business trends are in line with expectations and reflect the combined impact of:

- The full impact of the restructuring already deployed;

- Additional production capacities especially in the Nanjing liquid methionine plant which is reaching its full capacity of 140,000 tons p.a;

- The positive impact of new specialty products launched recently;

- Improved prices and margins on vitamins;

- Favorable economic environment with lower raw material prices based on low Brent oil level.

- A less favorable market environment in the methionine: after an exceptional 2015 year, operating revenues and operating income are lower as expected.

- Reduced demand for our dairy product due to global dairy market situation;

The increase in operating revenue in specialties product reflects constant innovation in new products, including products launched over the last few years, such as Selisseo? (a specialty product based on selenium) and Advance? (a new enzyme product).

During the first quarter of 2016, Adisseo launched a new probiotic product, Alterion?, in partnership with Novozymes. The product is based on beneficial bacteria that improve feed utilization and provide a natural alternative to antibiotic growth promoters on poultry farms.

Due to these factors, Q1 2016 net profit attributable to shareholders is in line with expectations and increased by 379%.

Cash flow evolution and dividend

The economic performance of Adisseo business explains the increase of net cash flow from operating activities.

To share the Company’s operation achievements with all shareholders, as well as enabling the Company for further development, the board of the Company, in consideration of the Company’s actual operation situations, proposes that: based on the Company’s total share capital of 2,681,901,273 shares dated 31, December, 2015, the Company will distribute to all shareholders, cash dividend of RMB 1.65 yuan per 10 shares (inclusive of tax). The total amount of the cash dividends to be distributed is 4.4 (100 million) Yuan. It is subject to the approval of the General Assembly.

GUIDANCE

On the basis of the Q1 2016 results, Adisseo reiterated its net profit attributable to shareholders budget for 2016, at 15.9 (100 million) Yuan up +4% over 2015.